Status of federally conducted agent orange studies : hearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, House of Representatives, Ninety-eighth Congress, first session, May 3, 1983

LDR 01360cam a2200313 a 4500
001 011345109
003 MiAaHDL
005 20110215000000.0
006 m d
007 cr bn ---auaua
008 840123s1983 dcu f000 0 eng c
010 ‡a 83602953
019 ‡a10079492
035 ‡asdr-pur1635664
035 ‡asdr-ucr.b20053939
035 ‡a1635664
035 ‡a(OCoLC)10063848
040 ‡aDGPO/DLC ‡cDLC ‡dOCLCQ
043 ‡an-us---
049 ‡aIPL1
050 0 0 ‡aKF27 ‡b.V462 1983b
082 0 ‡a363.1/79 ‡219
086 0 ‡aY 4.V 64/3:98-19
110 1 ‡aUnited States. ‡bCongress. ‡bHouse. ‡bCommittee on Veterans' Affairs. ‡bSubcommittee on Oversight and Investigations.
245 1 0 ‡aStatus of federally conducted agent orange studies : ‡bhearing before the Subcommittee on Oversight and Investigations of the Committee on Veterans' Affairs, House of Representatives, Ninety-eighth Congress, first session, May 3, 1983.
260 ‡aWashington : ‡bU.S. G.P.O. : ‡b[For sale by the Supt. of Docs., U.S. G.P.O., Congressional Sales Office], ‡c1983.
300 ‡aiii, 146 p. ; ‡c24 cm.
500 ‡aItem 1027-A, 1027-B (microfiche).
500 ‡a"Serial no. 98-19."
500 ‡aDistributed to depository libraries in microfiche.
538 ‡aMode of access: Internet.
650 0 ‡aVeterans ‡xMedical care ‡zUnited States.
650 0 ‡aAgent Orange ‡xPhysiological effect.
CID ‡a011345109
DAT 0 ‡a20101014203438.0 ‡b20110215000000.0
DAT 1 ‡a20120815064345.0 ‡b2020-09-20T17:55:14Z
DAT 2 ‡a2020-09-20T17:30:02Z
CAT ‡aSDR-PUR ‡dUNKNOWN ‡lloader.pl-001-001
FMT ‡aBK
HOL ‡0sdr-pur1635664 ‡apur1 ‡bSDR ‡cPUR ‡ppur1.32754078107392 ‡sPUR ‡11635664
974 ‡bPUR ‡cPUR ‡d20200920 ‡sgoogle ‡upur1.32754078107392 ‡y1983 ‡rpd ‡qbib ‡tUS fed doc
974 ‡bUC ‡cUCR ‡d20230717 ‡sgoogle ‡uuc1.31210024766600 ‡y1983 ‡rpd ‡qbib ‡tUS fed doc